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Introduction
One of the most aggressive and highly fatal cancers, pancreatic cancer has been dramatically increasing in incidence in China over the last 30 years. In urban Shanghai, average annual age-adjusted incidence rates (per 10 5 ) have risen among men from 3.7 in 1973 to 11.2 in 2000, and among women from 3.2 to 10.9 (1), beginning to approach rates seen in US whites.
Over the same period, incidence rates of pancreatic cancer among individuals of Chinese ancestry in California have remained at about 80% of the rates in whites. Factors explaining why the rates in Chinese may be lower than those in whites have not been determined.
In humans, risk factors for pancreatic cancer include gastric colonization by Helicobacter pylori, dietary intake of N-nitrosamines or of nitrites which form gastric N-nitrosamines, and cigarette smoking, also supplying N-nitrosamines (2) . Pathophysiologic actions of H. pylori colonization on gastric acidity have been suggested to modulate the pancreatic carcinogenic effect of N-nitrosamines or other carcinogens via hyperchlorhydria and increased risk of pancreatic cancer, or hypochlorhydria and decreased risk (2) . In a study of H. pylori colonization and risk of pancreatic cancer in Connecticut, where CagA-negative strains of the organism are comparable in frequency to CagA-positive ones (3), significantly increased risk was associated with seropositivity for CagA-negative strain and weakly decreased risk for CagApositive strain (3) , supporting the hypothesis of altered gastric acidity and risk because of the well-established contrasting effects of CagA-positive and -negative H. pylori strains associated with chronic gastric hypo-and hyperchlorhydria, respectively (4) . To examine this theory in a population with substantially different H. pylori colonization-where upwards of 70% of older individuals are colonized, overwhelmingly (95%) by CagA-positive strains-we undertook a population-based, case-control study of pancreatic cancer in urban Shanghai, China.
Materials and Methods

Participants
All study participants were Shanghai residents 35-79 years of age. An "instant case reporting system" of networked staff identified potential cases in the 37 major Shanghai hospitals where most individuals with pancreatic cancer are diagnosed and receive care.
Between December, 2006 and January, 2011, we identified 1,241 newly diagnosed patients reported to the Shanghai Cancer Institute. Of these, 149 had died, refused to participate, or were unable to be contacted, the remaining 1,092 (88%) recruited into the study. All relevant hospital records, pathology reports and slides, and/or imaging materials were obtained for later review of case eligibility by an expert panel of study pathologists and clinicians. Among the 1,092 patients, 200 were excluded because of diagnoses of benign, non-pancreatic or nonadenocarcinoma tumors, leaving 892 confirmed pancreatic cancer patients for analysis.
Over the same period, representative population control subjects were randomly selected from the Shanghai Residents Registry files according to categories of frequency matching by gender and age group. The Residents Registry enumerates all Shanghai permanent residents.
Contact was attempted for 1,653 candidates. Among those selected, 94 had been diagnosed with malignant diseases and 30 were deceased (all ineligible), 462 refused to participate, and the remaining 1,067 recruited as controls (70% participation of eligible subjects). The study was approved by the institutional human subjects review boards of the Shanghai Cancer Institute and Yale University.
Serologic evaluation
Participants signed informed consent, followed by in-person interview and phlebotomy.
Blood samples were obtained from 761 cases (85%) and 794 controls (74%). The samples (on ice) were transported immediately post-interview to the Shanghai Cancer Institute specimen processing laboratory, where they were promptly centrifuged, aliquotted into standard components and frozen at −80°C. After the study received export approval from the Chinese National Office for the Management of Human Genetic Resources, the aliquot samples were packed in thick Styrofoam boxes with large quantities of dry ice and air courier shipped to our laboratories at Yale. The still-frozen aliquots were then stored at −80°C until analysis. Prior to their shipment to the US, all study biosamples were labeled with identifying numbers bearing no relation to any personal identifying information, thus protecting participant anonymity.
Commercial IgG enzyme-linked immunosorbent assay (ELISA) kits were used for determination of plasma seropositivity for H. pylori (Scanlisa HM-CAP ® , Scimedx Corp., Denville, NJ) and for CagA-positive H. pylori strain (Ravo Diagnostika p120, Alere GmbH, Köln, Germany). In Shanghai subjects, the HM-CAP ® assay has measured sensitivity of 97% and specificity of 88% compared to urea breath test/histology (5, 6) . The widely used p120
CagA assay has measured sensitivity of 88% and specificity of 100% (7) . All study subjects were tested for both assays. Plasma samples blinded for case-control status were analyzed in duplicate along with calibration and quality-control samples in each assay plate. Titer values for all of the quality-control samples were well within their appropriate ranges; coefficients of variation for the calibration samples averaged 2.7% for the H. pylori and 2.3% for the CagA ELISAs. Seropositivity was assigned for calculated titer levels exceeding the manufacturers' 
Statistical analysis
For analyses of seropositivity with risk of pancreatic cancer, unconditional logistic regression methods were used to estimate odds ratios (ORs) and their 95% confidence intervals (CIs). All analyses were adjusted for continuous terms of interview age, age-21 BMI, and years of cigarette smoking, and a dichotomous term for gender. The GLIM computer program was used for calculations (11) . All P values are two-sided and based on 2× differences in model loglikelihoods referred to the chi-square distribution.
Results
Comparability of participants
Among our Shanghai study subjects, controls were comparable to cases on age, gender, and education (Table 1) . History of cigarette smoking and regular alcohol use differed very slightly, while average body mass index (BMI, weight/height 2 ) at age 21 years showed a statistical though not appreciable difference between cases and controls (Table 1 ). Cases and controls had similar BMI based on reported usual weight later in life during adulthood. The distributions of these factors were very similar comparing all interviewed subjects to the 761 cases and 794 controls providing blood samples (data not shown).
Associations with risk of pancreatic cancer
Associations with risk of pancreatic cancer according to H. pylori seropositivity and for CagA-positive and negative H. pylori strains are shown in various models in Table 2 . Both H.
pylori and CagA seropositivity were associated with significantly decreased risk. In contrast, CagA-negative H. pylori seropositivity, though not as common, was associated with significantly increased risk compared to non-CagA-negative H. pylori seropositivity (model 4). The association with CagA seropositivity remained about the same, whereas that with CagA-negative H. pylori seropositivity was attenuated somewhat, when both factors were included in the same model, with respect to a common reference group seronegative for both strain types (model 5).
No risk interactions were observed between CagA seropositivity and gender (P = 0.47), cigarette smoking (P = 0.62), or age-21 BMI (P = 0.28 
Discussion
Strengths and limitations
Because of the very high disease mortality, case-control studies of pancreatic cancer typically have very low case participation fractions compared to studies of other cancer sites, allowing for the possibility that sampled cases may not represent the general features of the disease. An important strength of our study was the involvement of networked staff in each of the 37 major Shanghai hospitals involved in the diagnosis and care of individuals with pancreatic cancer. This instant reporting network yielded the participation of 88% of eligible cases, perhaps the largest participation fraction of any pancreatic cancer case-control study of which we are aware. Our study also achieved a 70% participation fraction for controls, which value is comparable to control participation in many published high-quality case-control studies. Among our study participants, we obtained blood specimens from 85% of cases and 74% of controls which, in combination with the subject participation fractions and the sensitivity and specificity of the ELISA assays, could allow for some degree of potential misclassification and expected 
reduced magnitudes of association. However, on a number of characteristics, the study subjects that provided blood specimens were observed to be very similar to all enrolled subjects, and we did observe statistically significant associations, though their magnitudes may be underestimates.
A second consideration is that we obtained case-subject biospecimens after cancer diagnosis, creating the theoretical possibility that seropositivity could have changed because of effects of tumor development. However, it seems unlikely that effects of reverse causality explain our findings. Biosamples from all cases in our Shanghai study and most in our previous Connecticut study were obtained prior to treatment, removing chemotherapy as an explanation.
While immune senescence occurs with aging, our controls were matched to cases on age and age was included in all regression model adjustments. Any hypothetical effect that a developing pancreatic cancer might have on general immune function would be expected to apply equally to serotiters of antibodies to CagA-positive and CagA-negative strains of H. pylori. Among our H. pylori seropositive Shanghai subjects, H. pylori serotiters were similar for CagA-seropositive vs.
CagA-seronegative individuals, both for cases and controls. A parallel similar pattern was seen for our Connecticut subjects. Since our association results were in opposite directions for CagA+ vs H. pylori+ CagA− subjects, a general increase or decrease in immune seroreactivity caused by tumor development cannot be an explanation.
A superficially paradoxical finding in our data is that CagA seropositivity is more frequent than H. pylori seropositivity, the latter of which should reflect colonization by CagA- 
Interpretation of findings
Helicobacter pylori colonization differs appreciably between the US and China. In the US, over the last century and particularly after World War II, general increases in standards of living and development of suburban lifestyles with reduced population densities have led to significant declines in frequency of colonization by H. pylori (12) . Whereas the overwhelming majority of colonized individuals in China carry CagA-positive strains (e.g., 95% of seropositive controls in the present study), a smaller fraction of colonized persons in the US do so (65% of seropositive controls in our Connecticut study; ref. 3) , and seropositivity as a whole among adults is much lower in the US than in China, 24% vs. 71%, respectively, according to our data. in Shanghai and OR = 1.68 in Connecticut (3). When both CagA seropositivity and CagAnegative H. pylori seropositivity were simultaneously included in the same regression models, the effect on risk for CagA seropositivity was unchanged in the Shanghai study and that for CagA-negative H. pylori seropositivity unchanged in the Connecticut study, both remaining significant, whereas the remaining factor in each study changed toward unity.
Seven previous though smaller studies have examined the H. pylori association with pancreatic cancer. Four of these did not determine CagA seropositivity (13) (14) (15) (16) , and while providing some evidence for increased risk associated with H. pylori seropositivity (ORs and 
by the original ELISA, 9 (23%) tested negative with the newer ELISA. This raises the possibility that the null findings might have been influenced by the characteristics of the two custom ELISAs used. However, it is also possible that with non-negligible rates of H. pylori and CagA seroreversion (8-10), assays of serum samples obtained 22 years before diagnosis may yield different results from those obtained 4.6 years before diagnosis or at diagnosis. It is also possible that different risk associations may be conveyed by western versus Asian CagA-positive strains (20) , which differ in their virulence properties according to C-terminus variation in the CagA protein (21, 22) , and in associations between CagA-seropositivity and expression of other virulence factors such as VacA (23) .
Overall, the present large study and its consistency with the results of our previous large study provide indirect evidence for the involvement of gastric acidity and its bidirectional modification according to Helicobacter pylori CagA strain type in the risk of pancreatic cancer.
In contrast to other Helicobacter species, H. pylori does not colonize the pancreas in normal individuals and thus has no direct proximal effect on the pancreatic ductal epithelium (13, (24) (25) (26) . Gastric colonization by CagA-negative H. pylori is associated with antral-predominant gastritis and hyperchlorhydria, whereas colonization by CagA-positive H. pylori is associated with corpus atrophic gastritis and hypo-or achlorhydria (2, 4) . Aside from colonization of the gastric corpus vs. the antrum and corresponding inflammatory sequelae and atrophy, for the pancreas the major clinical pathophysiologic difference between CagA-positive and CagAnegative H. pylori colonization is the chronic reduced vs. increased gastric acid production, respectively (4). Eradication of H. pylori in duodenal ulcer patients (i.e., CagA-negative strains) returns their hyperchlorhydria to normal acidity (27, 28) , whereas eradication of CagA-positive H. pylori in corpus atrophic gastritis patients returns their hypo-or achlorhydria to normal (29) . 
